Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction

Respiratory Medicine

Volumn 85, Issue 6, 1991, Pages 495-500

  Mohammed, A F ^a,b,c   Anderson, K ^a,b,c   Matusiewicz, S P ^a,b,c   Boyd, G ^a,b,c   Greening, A P ^a,b,c   Thomson, N C ^a,b,c  

^a WESTERN INFIRMARY   (United Kingdom)

^b Belividere Hospital ^*  (United Kingdom)

^c Northern General Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; TREMOR;

EID: 0026044865     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(06)80267-2     Document Type: Article

References (22)

1. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma
2. To be taken as directed
3. Theophylline prescribing, serum levels and toxicity
4. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease
5. A comparison of a new osmotic pressure mediated oral formulation of salbutamol controlled release tablets (Volmax, SCR) and standard salbutamol tablets (SST) in the treatment of mild asthma in adults
6. Comparison of a new osmotic pressure mediated oral formulation of salbutamol controlled release tablets (Volmax, SCR) and standard salbutamol tablets (SST) in the treatment of childhood asthma — a multicentre study
7. A multicentre trial of salbutamol controled release tablets (Volmax) and standard salbutamol tablets (Ventolin) in the management of asthma and chronic bronchitis
8. Comparison between salbutamol controlled release tablets and slow release theophylline tablets in the management of chronic obstructive airways disease
9. Multicentre comparative study of salbutamol controlled release (Volmax) and sustained release theophylline (Theo-dur) in the control of nocturnal asthma
10. Reversing the irreversible
11. Double blind comparison of controlled release albuterol (Volmax, V) vs sustained release theophylline (T) in patients with chronic asthma
12. Comparison of extended release albuterol (Volmax, V) vs theophylline (T) vs placebo (P) in adults with chronic asthma
13. Efficacy and safety of twice-a-day albuterol (Volmax, V) vs theophylline (T) in asthmatic children
14. Physiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary disease
15. Effects of oral terbutaline in chronic airflow limitation
16. Two, six and 12-minute walking tests in respiratory disease
17. Bronchodilators in chronic air-flow limitation; effects on airway function, exercise capacity, and quality of life
18. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction
19. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction
20. Sustained-release theophylline reduces dyspnea in non-reversible obstructive airway disease
21. Effect of aminophylline on exercise performance in patients with irreversible airway obstruction
22. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects